Dose-response analysis of ranibizumab as-needed regimens for visual improvement in patients with diabetic macular edema using a modeling approach
Authors
Xiong Y, Pigeolet E, Mulyukov Z, Margaron P, Racine A, Clemens A
Journal
Contemp Clin Trials
Publication Date
2019
Impact Factor
2.640
Abstract
Additional IDs
Dose-response analysis of ranibizumab as-needed regimens for visual improvement in patients with diabetic macular edema using a modeling approach - Publication by Dr. Andreas Clemens | Dr. Andreas Clemens